| Tom Sean Cleary, PHD | |
|
16350 Filbert St, Mental Health, Sylmar, CA 91342-1002 | |
| (818) 364-2152 | |
| Not Available |
| Full Name | Tom Sean Cleary |
|---|---|
| Gender | Male |
| Speciality | Psychologist - Forensic |
| Location | 16350 Filbert St, Sylmar, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053490771 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TF0200X | Psychologist - Forensic | PSY 15990 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Tom Sean Cleary, PHD 16350 Filbert St, Mental Health, Sylmar, CA 91342-1002 Ph: (818) 364-2152 | Tom Sean Cleary, PHD 16350 Filbert St, Mental Health, Sylmar, CA 91342-1002 Ph: (818) 364-2152 |
News Archive
Many important clinical and basic scientific advances have been made in the past five years in the field of neuro-oncology, according to an editorial and several articles in the March issue of Archives of Neurology, one of the JAMA/Archives journals.
An elevated resting heart rate that develops or persists during follow-up is associated with a significantly increased risk of death, whether from heart disease or other causes, researchers from the Ronald O. Perelman Heart Institute at NewYork-Presbyterian Hospital/Weill Cornell Medical Center found studying outcomes in more than 9,000 patients.
Bruker announced today that it has successfully installed its BioSpec® 170/25 system at the CEA NeuroSpin research center near Paris, France. The world's first horizontal ultra-high magnetic field 17.2 Tesla MRI system features a magnet bore diameter of 25 cm. It is equipped with a novel Bruker BGA-S™ gradient system with unsurpassed amplitude and slew rate specifications for cutting-edge preclinical in vivo imaging on small animals.
Adolescents who are tasered by law enforcement officers do not appear to be at higher risk for serious injury than adults, according to new a new study from Wake Forest Baptist Medical Center researchers.
Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted priority review status to the company's New Drug Application (NDA) for the investigational agent eribulin mesylate ("eribulin," also known as E7389). Eisai is seeking FDA approval for eribulin in the treatment of patients with locally advanced or metastatic breast cancer previously treated with at least two chemotherapy regimens, including an anthracycline and a taxane.
› Verified 9 days ago
Dr. Edward Scott Stella, Psychologist Medicare: Medicare Enrolled Practice Location: 12220 Foothill Blvd, Sylmar, CA 91342 Phone: 818-612-0591 | |
Dr. Elaine R Powell, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 16350 Filbert St, Sylmar, CA 91342 Phone: 818-364-2152 Fax: 818-833-5438 | |
Zoada Harris, PH.D Psychologist Medicare: Not Enrolled in Medicare Practice Location: 16350 Filbert St, Department Of Mental Health, Sylmar, CA 91342 Phone: 818-364-2152 | |
Dr. Evlin Abed, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 16350 Filbert St, Sylmar, CA 91342 Phone: 818-364-2152 | |
Dr. Maria Yvonne Scott, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 16350 Filbert St, Sylmar, CA 91342 Phone: 818-364-6881 | |
Ralph Williams, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 16350 Filbert St, Department Of Mental Health, Sylmar, CA 91342 Phone: 818-364-2152 |